Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA
hsa-miR-3651
Specific or universal ncRNAs
Specific ncRNAs
Class
MicroRNA
Biomarker
None
Biomarker application
Upstream regulatory factor
Not available
Downstream target
FRMD3
Differential expression in
recurrence vs. nonrecurrence
Up
Cancer name
Breast Cancer
Alias
Cancer site
Breast
Recurrence type
Recurrence
Overall survival rate of patients with
high ncRNA expression
Not available
ncRNA differential expression in
cancer
patients vs. health people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
Recurrence patients
Not available
Recurrence patients male:female
Not available
Recurrence patients age range
Not available
Recurrence mean age
Not available
Sites of recurrence
Not available
Patients without recurrence
Not available
Patients without recurrence male:female
Patients without recurrence age range
Not available
Patients without recurrence mean age
Not available
PMID
Description
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3
Tissue resource
tumor tissue from patients with early stage breast cancer
Experiment
qRT-PCR
Institute
Paracelsus Medical University
Country
Austria
Continent
European
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.